Protective Effects of Rhamnetin in Carbapenem-Resistant Acinetobacter baumannii-Induced Sepsis Model and the Underlying Mechanism

Int J Mol Sci. 2023 Oct 26;24(21):15603. doi: 10.3390/ijms242115603.

Abstract

Carbapenem-resistant Acinetobacter baumannii (CRAB) is a well-known harmful bacterium that causes severe health disorders and dysregulates the host immune response associated with inflammation. Upon examining the suppressive activity of natural flavonoid rhamnetin on various pro-inflammatory cytokines in a CRAB-induced septic shock mouse model, we found that rhamnetin inhibited the production of IL-1β and IL-18, two pro-inflammatory cytokines associated with pyroptotic cell death, a process dependent on caspase-1. In this study, we investigated the antioxidant and anti-apoptotic activities of rhamnetin and the underlying mechanism of action in a CRAB infection. In the CRAB-induced septic shock mouse model, rhamnetin reduced the level of lipopolysaccharide (LPS) in lung lysates, resulting in the inhibition of TLR4-mediated inflammatory signaling. Notably, rhamnetin reduced intracellular reactive oxygen species (ROS) generation in macrophages and inhibited apoptotic and pyroptotic cell injury induced by CRAB infection. Therefore, rhamnetin inhibited LPS-induced pro-inflammatory mediators, hindering apoptotic and pyroptotic processes and contributing to a recovery effect in CRAB-induced sepsis mice by suppressing oxidative stress. Taken together, our study presents the potential role of rhamnetin in protecting against oxidative damage induced by CRAB infection through a TLR4 and ROS-mediated pyroptotic pathway, showing an alternative mechanism for sepsis prevention. Therefore, rhamnetin is a promising therapeutic candidate for treating CRAB-induced sepsis.

Keywords: ROS; antioxidant; apoptosis; carbapenem-resistant Acinetobacter baumannii; rhamnetin; sepsis.

MeSH terms

  • Acinetobacter baumannii*
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Carbapenems / pharmacology
  • Cytokines / pharmacology
  • Lipopolysaccharides / toxicity
  • Mice
  • Microbial Sensitivity Tests
  • Reactive Oxygen Species / pharmacology
  • Sepsis* / chemically induced
  • Sepsis* / drug therapy
  • Shock, Septic*
  • Toll-Like Receptor 4

Substances

  • rhamnetin
  • Reactive Oxygen Species
  • Lipopolysaccharides
  • Toll-Like Receptor 4
  • Cytokines
  • Carbapenems
  • Anti-Bacterial Agents

Grants and funding